Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Abstract Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel...
Saved in:
| Published in: | Thrombosis and haemostasis Vol. 120; no. 7; pp. 1004 - 1024 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Stuttgart · New York
Georg Thieme Verlag KG
01.07.2020
|
| Subjects: | |
| ISSN: | 0340-6245, 2567-689X, 2567-689X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!